Home › Employers › MEDIC Life Sciences, Inc
MEDIC Life Sciences, Inc: H-1B salaries and sponsorship
MEDIC Life Sciences, Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $59,342.
Does MEDIC Life Sciences, Inc sponsor H-1B visas?
MEDIC Life Sciences, Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 19, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Research Associate | 3 | $55,578 |
| Research Associate I | 1 | $63,107 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 2 | $55,578 |
| FY2026 | 2 | $63,107 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Research Associate I | $63,107–$63,110 Level II | Palo Alto, CA | May 19, 2026 | Oct 1, 2026 | Certified |
| Research Associate | $63,107–$65,000 part-time · Level II | Palo Alto, CA | Jan 26, 2026 | Feb 1, 2026 | Certified |
| Research Associate | $55,578–$57,000 Level II | Mountain View, CA | Jun 12, 2024 | Oct 1, 2024 | Certified |
| Research Associate | $73,778–$81,328 part-time · Level IV | Mountain View, CA | Jun 12, 2024 | Oct 1, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).